T. Mae

Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648

Kenji Fujii, Hideyuki Saito, Hiromi Tomioka et al. · Antimicrobial Agents and Chemotherapy · 1995 · 33 citations · Full text

Bioorganic Chemistry, Antimicrobial Chemotherapy, Antimycobacterial Activity +17

Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog

T. Mae, Kazunori Hosoe, T. Yamamoto et al. · Xenobiotica · 1998 · 32 citations

Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs

Kazunori Hosoe, T. Mae, Eisaku Konishi et al. · Antimicrobial Agents and Chemotherapy · 1996 · 29 citations · Full text

Health Sciences, Pharmacodynamics, Pharmacological Study +14

Identification of enzymes responsible for rifalazil metabolism in human liver microsomes

T. Mae, T. Inaba, Eisaku Konishi et al. · Xenobiotica · 2000 · 25 citations

Rifalazil Metabolism, Major Metabolites, Toxicological Mechanism +19

Inhibitory Effects of Vitamin A and Vitamin K on Rat Cytochrome P4501A1-Dependent Monooxygenase Activity

Kuniyo Inouye, T. Mae, Shunya Kondo et al. · Biochemical and Biophysical Research Communications · 1999 · 24 citations

Inhibitory Effects, Biochemistry, Medicine +9